原発性肝癌の鑑別診断のためのエクソソームを用いた液体生検

基本情報

NCT ID: NCT06342414
ステータス: 募集中
試験のフェーズ: -
試験タイプ: 観察
目標被験者数: 400
治験依頼者名: City of Hope Medical Center

概要

It is sometimes difficult to precisely understand whether a primary liver cancer is a hepatocellular carcinoma or a cholangiocarcinoma. The researchers will develop and validate a liquid biopsy, based on exosomal content analysis and powered by machine learning, to help clinicians differentiate these two cancers before surgery.

対象疾患

Hepatocellular CarcinomaIntrahepatic CholangiocarcinomaCholangiocarcinomaPrimary Liver CancerPrimary Liver CarcinomaHepatic CancerHepatic Carcinoma

介入

ELUCIDATE(DIAGNOSTIC_TEST)

依頼者（Sponsor）

City Of Hope Medical Center(OTHER)

実施施設 (4)

公立学校共済組合　九州中央病院

Fukuoka, Japan(RECRUITING)

Graduate School of Medical Sciences, Kumamoto University

Kumamoto, Japan(RECRUITING)

Tokushima University

Tokushima, Japan(RECRUITING)

北海道大学病院

Sapporo, Japan(RECRUITING)